Shaheda Azher is a Neurology physician. OpenAlex indexes 5 publications with 497 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
30 Columbia St
Poughkeepsie, NY 126013906
Telephone
845-231-5600Registry record last updated 15 Nov 2016.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AbbVie Inc.Program year20233 payments
- ABBVIE INC.Program year20223 payments
- AstraZeneca Pharmaceuticals LPProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
54.2%Neuromuscular Blocker51.5%Onabotulinumtoxina100%Part B, office-administered≥11 patientsgamma-Aminobutyric Acid-ergic Agonist1.4%Baclofen100%Part D≥24 patients+ 3 more classes in this area
Nervous system
43%Cholinesterase Inhibitor6.5%Donepezil Hcl97%Rivastigmine3%Part D<11 patientsOther antiepileptics5.6%Levetiracetam69%Topiramate17%Lacosamide7%Levetiracetam Er3%Vimpat2%Keppra2%Part D<11 patients+ 21 more classes in this area
Cardiovascular
1.3%Beta blocker0.8%Propranolol Hcl59%Propranolol Hcl Er41%Part D<11 patientsStatin0.5%Atorvastatin Calcium43%Pravastatin Sodium30%Simvastatin27%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis
Movement Disorders
2006 - A Method for Estimating Duration of Illness in Alzheimer’s Disease
Dementia and Geriatric Cognitive Disorders
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”